Biocryst Pharmaceuticals buy Wedbush
Start price
25.02.25
/
50%
€7.80
Target price
25.02.26
€14.28
Performance (%)
-18.20%
Price
18:34
€6.38
Summary
This prediction is currently active. The prediction for Biocryst Pharmaceuticals disappoints with a performance of -18.20%. This prediction currently runs until 25.02.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -1.073% | -1.073% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Wedbush for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $15.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Wedbush for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.60
30.06.25
30.06.25
€15.36
30.06.26
30.06.26
-16.02%
18:34
18:34
